Search research articles
Contact Us
Filters
Showing results (101-110 of 145) with videos related to
Page
of 15
Sort By:
Investigational New Drugs
|
January 1, 1994
Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro
B T Hill, R D Whelan, S A Shellard, et al.
BMC Medical Research Methodology
|
November 26, 2011
Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods
Bette Liu, Julia M L Brotherton, David Shellard, et al.
Anti-Cancer Drugs
|
June 1, 1994
Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines
B T Hill, S A Shellard, A M Fichtinger-Schepman, et al.
Experimental Hematology
|
February 1, 1991
Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL)
J E Shellard, H A Leitch, P M Logan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1990
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation
B T Hill, S A Shellard, L K Hosking, et al.
Carcinogenesis
|
July 1, 1992
Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro
W C Dempke, S A Shellard, L K Hosking, et al.
The Journal of Biological Chemistry
|
October 13, 2012
Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation
Atul Goyal, Chiara Poluzzi, Chris D Willis, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1988
Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro
B T Hill, R D Whelan, L K Hosking, et al.
Cancer Treatment Reviews
|
December 1, 1990
Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation
B T Hill, R D Whelan, L K Hosking, et al.
International Journal of Cancer
|
November 15, 1987
Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin
P Bedford, S A Shellard, M C Walker, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 145) with videos related to
Sort By:
Page
of 15
Investigational New Drugs
|
January 1, 1994
Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro
B T Hill, R D Whelan, S A Shellard, et al.
BMC Medical Research Methodology
|
November 26, 2011
Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods
Bette Liu, Julia M L Brotherton, David Shellard, et al.
Anti-Cancer Drugs
|
June 1, 1994
Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines
B T Hill, S A Shellard, A M Fichtinger-Schepman, et al.
Experimental Hematology
|
February 1, 1991
Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL)
J E Shellard, H A Leitch, P M Logan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1990
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation
B T Hill, S A Shellard, L K Hosking, et al.
Carcinogenesis
|
July 1, 1992
Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro
W C Dempke, S A Shellard, L K Hosking, et al.
The Journal of Biological Chemistry
|
October 13, 2012
Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation
Atul Goyal, Chiara Poluzzi, Chris D Willis, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1988
Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro
B T Hill, R D Whelan, L K Hosking, et al.
Cancer Treatment Reviews
|
December 1, 1990
Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation
B T Hill, R D Whelan, L K Hosking, et al.
International Journal of Cancer
|
November 15, 1987
Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin
P Bedford, S A Shellard, M C Walker, et al.
Page
of 15